Results 121 to 130 of about 5,051 (197)

Epidemiology, mechanisms, and clinical impact of bacterial heteroresistance

open access: yesnpj Antimicrobials and Resistance
Bacterial heteroresistance, a phenomenon where subpopulations within a bacterial strain exhibit significantly reduced antibiotic susceptibility compared to the main population, poses a major challenge in managing infectious diseases.
Linna Xu   +5 more
doaj   +1 more source

Impact of time to appropriate therapy on mortality in patients with vancomycin-intermediate Staphylococcus aureus infection [PDF]

open access: yes, 2016
Despite the increasing incidence of vancomycin-intermediate Staphylococcus aureus (VISA) infections, few studies have examined the impact of delay in receipt of appropriate antimicrobial therapy on outcomes in VISA patients.
Burnham, Carey-Ann D   +3 more
core   +2 more sources

Helicobacter pylori and Its Antibiotic Heteroresistance: A Neglected Issue in Published Guidelines

open access: yesFrontiers in Microbiology, 2019
“Heteroresistance” is a widely applied term that characterizes most of the multidrug-resistant microorganisms. In microbiological practice, the word “heteroresistance” indicates diverse responses to specific antibiotics by bacterial subpopulations in the
Albert A. Rizvanov   +6 more
doaj   +1 more source

Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study [PDF]

open access: yes, 2017
Objectives Treatment outcome of MDR-TB is critically dependent on the proper use of second-line drugs as per the result of in vitro drug susceptibility testing (DST).
Böttger, E. C.   +12 more
core  

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration Indicações da evolução da resistência ao carbapenem através da heteroresistência como estágio intermediário no Acinetobacter baumannii após administração de carbapenem

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2009
We describe an in vivo evolution of an antimicrobial profile from susceptibility to full-resistance to carbapenems, with heteroresistance as an intermediate stage, in an Acinetobacter baumannii strain.
Silvana Vargas Superti   +5 more
doaj   +1 more source

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. [PDF]

open access: yes, 2017
Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis remains out of control in several parts of the world including Africa and Asia.
Atre, Sachin R   +41 more
core   +1 more source

Heteroresistance to carbapenems in Acinetobacter baumannii [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2005
S, Pournaras   +4 more
openaire   +2 more sources

The dynamic distribution of genetic tandem amplifications in a heteroresistant Escherichia coli population revealed by ultra-deep long read sequencing

open access: yesNature Communications
Antibiotic heteroresistance, characterized by rare resistant subpopulations of bacteria within a susceptible main population, is associated with treatment failure and often caused by tandem amplification of resistance genes. Here, we investigated how the
Sofia Jonsson   +4 more
doaj   +1 more source

Vancomycin Heteroresistance in Methicillin-resistantStaphylococcus aureus, Taiwan

open access: yesEmerging Infectious Diseases, 2004
To the Editor: In 1997, Hiramatsu and colleagues reported the first clinical isolate of methicillin-resistant Staphylococcus aureus (MRSA) showing reduced susceptibility to vancomycin (1). Soon thereafter, vancomycin-intermediate S. aureus (VISA) or heteroresistant VISA was reported to have disseminated in Japanese hospitals (2). In Taiwan, a survey of
Wang, Jiun-Ling   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy